leishmania
infantum
syn
l
chagasi
intracellular
protozoon
caus
sever
system
diseas
name
viscer
leishmaniasi
vl
wide
distribut
mediterranean
basin
middl
east
south
america
vl
annual
incid
approxim
case
brazil
declar
total
clinic
vl
case
number
account
report
vl
case
america
howev
subject
substanti
underreport
differ
geograph
region
globe
viscer
leishmaniasi
endem
present
dog
main
reservoir
l
chagasi
play
relev
role
transmiss
parasit
dog
also
excel
model
studi
vl
natur
histori
diseas
dog
human
similar
especi
regard
interact
immun
respons
develop
new
vaccin
natur
histori
canin
vl
cvl
welldescrib
particularli
regard
parasit
load
differ
tissu
immunopatholog
chang
accord
progress
clinic
form
vaccin
cvl
would
import
tool
control
vl
would
decreas
anxieti
associ
l
chagasi
infect
human
induct
longlast
cellmedi
immun
respons
trigger
high
level
protect
cvl
consid
prerequisit
ideal
vaccin
control
l
chagasi
transmiss
differ
vaccin
candid
cvl
report
show
abil
induc
immunoprotect
mechan
sens
shown
fucos
manos
ligand
plu
saponin
adjuv
zoeti
paulo
brazil
present
protect
phase
iii
studi
provid
protect
associ
abil
trigger
earli
persist
activ
neutrophil
monocyt
addit
activ
lymphocyt
display
high
level
tcell
subset
addit
vaccin
hertap
calier
juatuba
brazil
antigen
plu
saponin
adjuv
also
shown
induc
increas
level
four
seven
dog
l
chagasiinfect
bone
marrow
recent
vaccin
compos
excretedsecret
antigen
l
infantum
promastigot
refer
liesap
shown
induc
increas
level
nitric
oxid
thu
support
leishmanicid
effect
efficaci
liesap
vaccin
report
doubleblind
random
studi
liesap
commerci
avail
virbac
carro
franc
abl
induc
profil
reduc
parasit
load
infect
macrophag
cocultur
lymphocyt
immun
dog
lbsap
l
braziliensi
crude
antigen
plu
saponin
adjuv
lbsapsal
l
braziliensi
crude
antigen
plu
saponin
adjuv
lutzomyia
longipalpi
saliva
vaccin
cvl
also
shown
induc
strong
immunemedi
respons
lbsap
lbsapsal
present
higher
level
circul
tcell
subset
b
lymphocyt
well
leishmaniaspecif
cell
furthermor
lbsapvaccin
dog
present
high
low
interleukin
il
transform
growth
factor
tgf
express
spleen
result
signific
reduct
parasit
load
tissu
addit
lbsap
shown
induc
promin
proinflammatori
immun
respons
character
increas
level
decreas
level
peripher
blood
mononuclear
cell
pbmc
associ
parasit
control
dog
incorpor
salivari
protein
sand
fli
wide
use
experiment
challeng
studi
result
suggest
could
good
strategi
protect
leishmania
infect
previou
studi
dog
use
lbsapsal
vaccin
display
higher
count
circul
leishmaniaspecif
cell
addit
high
nitric
oxid
product
reduct
splenic
parasit
load
consid
inclus
saliva
sand
fli
promis
compound
vaccin
leishmania
infect
describ
addit
biomark
induc
lbsapsal
vaccin
dog
consid
previou
vaccin
protocol
postvaccin
protocol
earli
late
period
l
chagasichalleng
research
involv
dog
carri
accord
regul
brazilian
societi
scienc
anim
research
adopt
feder
univers
ouro
preto
ethic
committe
anim
experiment
approv
technic
procedur
use
dog
protocol
number
dog
includ
studi
born
bred
kennel
facil
universidad
feder
de
ouro
preto
ouro
preto
mina
gerai
brazil
kennel
facil
establish
male
femal
mongrel
dog
neg
serolog
molecularparasitolog
diagnosi
leishmania
infect
donat
local
zoonosi
control
center
belo
horizont
mina
gerai
brazil
filial
gener
compris
offspr
result
cross
origin
mongrel
dog
pair
use
maintain
mongrel
dog
coloni
present
studi
twenti
mongrel
dog
male
femal
seven
month
age
neg
result
indirect
fluoresc
immunoassay
antileishmania
antibodi
select
receiv
antihelmint
treatment
submit
polyvaccin
protocol
includ
rabi
tecpar
curitibapr
brazil
leptospira
parvoviru
canin
distemp
type
ii
adenoviru
parainfluenza
coronaviru
htlp
pfizer
anim
health
new
york
ny
usa
prior
experiment
onset
anim
maintain
quarantin
kennel
run
length
x
width
x
height
complet
cover
stainless
steel
wire
mesh
prevent
entri
sand
fli
kennel
facil
spray
pyrethroid
insecticid
everi
three
month
measur
control
insect
access
run
instal
infrar
lamp
heat
watt
ensur
thermal
comfort
anim
night
cold
day
dog
hous
without
environment
enrich
eg
toy
exercis
regim
etc
dog
monitor
twice
day
routin
inspect
respons
veterinari
charg
stimul
play
aim
avoid
behavior
problem
minim
suffer
distress
throughout
studi
experiment
procedur
describ
studi
includ
aspect
anim
care
approv
feder
univers
ouro
preto
ethic
committe
anim
experiment
protocol
number
anim
maintain
water
food
ad
libitum
throughout
experi
time
euthanasia
dog
perform
supervis
veterinarian
physician
use
barbitur
anesthet
thiopent
sodium
iv
follow
intraven
inject
satur
solut
potassium
chlorid
four
group
dog
involv
experi
treat
follow
control
c
group
n
subcutan
inject
steril
salin
ii
sal
group
n
subcutan
inject
salivari
lutzomyia
longipalpi
gland
extract
sge
obtain
previous
steril
salin
iii
lbsal
group
n
subcutan
inject
l
braziliensi
promastigot
antigen
sge
steril
salin
iv
lbsapsal
group
n
subcutan
inject
l
braziliensi
promastigot
antigen
plu
saponin
sge
steril
salin
anim
receiv
three
inject
right
flank
interv
l
chagasiexperiment
challeng
dog
perform
day
vaccin
protocol
use
intraderm
promastigot
stationari
phase
cultiv
challeng
perform
inner
side
left
ear
includ
five
lutzomyia
longipalpi
salivari
gland
acini
analyz
dog
euthan
day
l
chagasiexperiment
challeng
spleen
collect
evalu
parasit
load
rational
choos
long
endpoint
day
challeng
base
chronic
cours
experiment
canin
viscer
leishmaniasi
intraderm
l
chagasichalleng
previous
report
vaccin
obtain
previous
describ
briefli
l
braziliensi
promastigot
obtain
vitro
cultur
neal
novi
nicolleliv
infus
triptos
media
parasit
fulli
disrupt
ultrasound
treatment
aliquot
store
protein
concentr
determin
accord
method
lowri
sge
use
studi
antigen
compon
vaccin
obtain
lutzomyia
longipalpi
femal
fed
age
day
dissect
slightli
hypoton
unbuff
salin
describ
collect
gland
disrupt
sonic
second
centrifug
supernat
collect
store
freezer
use
jugular
vein
use
collect
peripher
blood
steril
heparin
syring
analyz
distinct
time
baselin
vaccin
day
third
immun
dose
well
earli
late
experiment
l
chagasichalleng
pbmc
isol
previous
describ
briefli
whole
blood
sampl
ad
ficollhypaqu
sigma
usa
centrifug
min
room
temperatur
pbmc
wash
twice
rpmi
min
room
temperatur
pbmc
resuspend
rpmi
cellsml
pbmc
cultur
perform
flatbottom
tissu
cultur
plate
costar
cambridg
usa
vitro
assay
perform
use
pbmc
cellswel
vaccin
l
braziliensissolubl
antigen
vsa
solubl
l
chagasi
antigen
slca
control
cultur
cc
unstimul
analyz
use
rpmi
place
antigen
stimulu
incub
perform
humidifi
atmospher
day
time
supernat
collect
store
freezer
detect
cytokin
quantif
cytokin
carri
enzymelink
immunosorb
assay
elisa
accord
manufactur
instruct
r
system
minneapoli
mn
usa
previous
describ
minimum
cytokin
sensit
detect
level
analysi
anticanin
catalog
number
anticanin
catalog
number
tumor
necrosi
factor
tnf
anticanin
immunoassay
catalog
number
anticanin
catalog
number
cytokin
perform
use
duoset
elisa
kit
mouseratporcinecanin
immunoassay
catalog
number
r
system
minneapoli
mn
usa
use
measur
level
analysi
level
employ
captur
antibodi
monoclon
anticanin
number
standard
curv
obtain
use
recombin
canin
catalog
number
streptavidin
r
systemsusa
biotinyl
anticanin
antibodi
catalog
number
substrat
solut
mixtur
tetramethylbenzidin
product
code
use
experi
perform
accord
instruct
r
system
use
plate
corn
incorpor
washington
dc
usa
micropl
automat
reader
biotek
winosski
vt
usa
employ
wavelength
measur
level
supernat
pbmc
cultur
perform
indirect
method
quantifi
nitrit
concentr
griess
reaction
briefli
griess
reagent
sulfanylamid
naphthylethylenediamidedihydrochlorid
phosphor
acid
sigma
usa
mix
aliquot
cellfre
cultur
supernat
micropl
reader
biotek
use
analyz
absorb
min
incub
room
temperatur
dark
final
nitrit
concentr
determin
base
standard
curv
interpol
construct
use
sodium
nitrit
solut
rang
interfer
nitrit
alreadi
present
cultur
medium
discount
data
calcul
take
account
blank
control
reaction
assay
use
pbmc
cultur
medium
data
express
nitrit
concentr
spleen
specimen
collect
necropsi
store
use
dna
extract
genom
dna
purif
kit
promega
madison
wi
usa
use
extract
total
genom
dna
spleen
follow
manufactur
recommend
primer
amplifi
fragment
singl
copi
dna
polymeras
gene
l
chagasi
use
analyz
spleen
parasit
burden
quantit
polymeras
chain
reaction
qpcr
q
pcr
analysi
forward
revers
primer
templat
dna
green
reaction
master
mix
appli
biosystem
grand
island
ny
usa
use
final
volum
previous
describ
use
target
dna
polymeras
gene
l
chagasi
genbank
access
pair
primer
forward
tgt
cgc
ttg
cag
acc
aga
tg
revers
gca
tcg
cag
gtg
tga
gca
c
pcr
reaction
employ
initi
denatur
min
denatur
cycl
second
addit
anneal
extens
pgemh
plasmid
promega
use
construct
stardart
curv
run
contain
insert
interest
gapdh
gene
fragment
genbank
access
number
use
analyz
integr
sampl
primer
ttccacggcacagtcaag
forward
actcagcaccagcatcac
revers
use
gapdh
gene
amplif
spleen
parasit
load
perform
duplic
calcul
interpol
standard
curv
includ
experiment
batch
data
express
number
l
chagasi
total
dna
prism
softwar
packag
prism
softwar
irvin
ca
usa
use
evalu
data
distribut
normal
kolmogorovsmirnoff
test
statist
analys
oneway
analysi
varianc
anova
follow
tukey
multipl
comparison
use
comparison
cytokin
profil
level
parasit
load
amongst
experiment
group
student
ttest
use
intragroup
comparison
control
cultur
cc
antigenstimul
cultur
vsa
slcastimuli
vitro
pearson
correl
analysi
appli
evalu
relationship
spleen
parasit
burden
profil
addit
cytokin
network
assembl
use
cytoscap
softwar
version
institut
system
biolog
seattl
usa
experiment
group
control
sal
lbsal
lbsapsal
time
analyz
base
correl
indic
obtain
pearson
correl
analysi
network
construct
use
distinct
edg
node
identifi
neg
posit
correl
refer
moder
r
strong
r
case
signific
consid
p
aim
verifi
whether
immun
protocol
abl
induc
product
proinflammatori
cytokin
evalu
profil
cc
upon
vsa
slcastimuli
vitro
signific
differ
observ
amongst
experiment
group
baselin
fig
upper
panel
data
analysi
perform
postvaccin
show
differ
level
amongst
experiment
group
regardless
cultur
condit
analysi
demonstr
lbsapsal
group
display
increas
level
p
upon
vsastimul
compar
cultur
control
sal
lbsal
group
fig
middl
panel
moreov
lbsal
group
show
reduc
level
p
upon
slcastimul
compar
control
group
fig
middl
panel
interestingli
analysi
show
lbsapsal
group
present
increas
level
p
cc
compar
control
group
fig
middl
panel
addit
lbsapsal
group
display
increas
level
p
upon
vsa
slcastimuli
comparison
control
sal
lbsal
group
fig
middl
panel
analysi
cytokin
profil
earli
l
chagasichalleng
demonstr
lbsapsal
group
show
signific
increas
level
p
upon
vsastimul
compar
sal
lbsal
group
fig
middl
panel
differ
level
observ
amongst
experiment
group
regardless
cultur
condit
analysi
lbsapsal
group
display
increas
level
p
upon
vsastimul
compar
control
lbsal
group
fig
middl
panel
addit
lbsapsal
group
show
signific
increas
p
upon
slcastimul
compar
control
group
fig
middl
panel
data
analysi
late
l
chagasichalleng
demonstr
lbsal
group
display
increas
level
p
upon
slcastimul
compar
control
group
fig
bottom
panel
addit
lbsapsal
group
display
higher
level
p
upon
vsastimul
compar
lbsal
group
fig
bottom
panel
differ
level
observ
amongst
experiment
group
regardless
cultur
condit
interestingli
analysi
reveal
lbsapsal
group
show
higher
level
p
upon
vsastimul
compar
control
sal
lbsal
group
fig
bottom
panel
aim
evalu
whether
immun
protocol
would
induc
regulatoryantiinflammatori
cytokin
quantifi
level
upon
vsa
slcastimuli
vitro
signific
differ
observ
amongst
experiment
group
baselin
fig
upper
panel
result
observ
postvaccin
period
demonstr
lbsal
group
show
signific
reduct
level
p
upon
vsastimul
compar
sal
group
fig
middl
panel
differ
level
observ
amongst
experiment
group
regardless
cultur
condit
data
mine
perform
earli
l
chagasichalleng
reveal
differ
product
amongst
experiment
group
regardless
cultur
condit
howev
lbsapsal
group
show
signific
reduct
level
p
upon
slcastimul
compar
sal
group
fig
middl
panel
interestingli
lbsapsal
group
also
present
signific
reduct
level
p
upon
slcastimul
compar
control
group
fig
middl
panel
analysi
carri
late
l
chagasichalleng
differ
level
amongst
experiment
group
regardless
cultur
condit
result
show
lbsal
group
present
signific
reduct
level
p
upon
vsastimul
compar
sal
group
fig
bottom
panel
interestingli
lbsapsal
group
display
signific
reduct
level
p
upon
slcastimul
compar
control
group
fig
bottom
panel
aim
identifi
overal
balanc
evalu
cytokin
appli
machinelearn
approach
analyz
cytokin
network
immun
protocol
gener
upon
slca
vsastimuli
vitro
fig
fig
cytokin
balanc
calcul
ratio
experiment
group
cultur
condit
data
provid
fig
result
reenforc
abil
lbsapsal
vaccin
induc
long
last
ifn
product
synthesi
regardless
antigenstimuli
fig
data
mine
system
biolog
tool
use
gener
biomark
network
experiment
group
use
vsa
slcastimuli
result
demonstr
upon
vsastimul
control
group
present
neg
correl
vsa
stimulu
posit
correl
also
observ
upon
slcastimul
posit
correl
observ
along
neg
correl
fig
upper
left
panel
sal
group
present
upon
vsastimul
rang
posit
correl
includ
along
addit
neg
correl
observ
analysi
upon
slcastimul
demonstr
posit
correl
amongst
proinflammatori
cytokin
along
posit
correl
fig
upper
right
panel
analysi
lbsal
group
upon
vsastimul
demonstr
singl
neg
correl
fig
bottom
left
panel
data
analysi
demonstr
upon
vsastimul
lbsapsal
group
show
strong
posit
correl
among
along
posit
correl
neg
correl
also
observ
amongst
fig
bottom
right
panel
moreov
upon
slcastimul
posit
correl
observ
fig
bottom
right
panel
parasitolog
analysi
perform
spleen
sampl
later
follow
l
chagasichalleng
report
number
l
chagasi
total
dna
spleen
sampl
present
tabl
data
analysi
demonstr
vaccin
protocol
abl
induc
reduct
splenic
parasit
load
compar
control
group
inde
sal
lbsal
group
yield
reduct
spleen
parasit
load
total
dna
respect
compar
control
group
total
dna
lbsapsal
group
show
lowest
parasit
load
total
dna
lead
reduct
rate
relat
control
group
tabl
moreov
clinic
sign
mortal
observ
throughout
experiment
design
tabl
level
nitric
oxid
produc
pbmc
evalu
upon
vsa
slcastimuli
vitro
earli
late
l
chagasichalleng
data
analysi
carri
earli
l
chagasichalleng
demonstr
lbsapsal
group
present
upon
control
cultur
condit
enhanc
level
p
compar
sal
group
fig
upper
left
panel
addit
sal
lbsapsal
group
show
increas
level
p
upon
vsastimul
compar
control
lbsap
group
fig
upper
left
panel
analysi
perform
late
l
chagasichalleng
show
lbsapsal
group
display
higher
level
p
upon
slcastimul
compar
control
group
fig
upper
right
panel
addit
analysi
reveal
product
display
neg
correl
spleen
parasit
load
select
upon
slcastimul
fig
bottom
right
panel
interestingli
observ
lbsapsal
group
four
five
anim
show
simultan
high
product
low
spleen
parasit
load
compat
protect
profil
fig
bottom
right
panel
contrast
control
group
one
five
show
high
product
anim
present
high
spleen
parasit
fig
bottom
right
panel
control
leishmania
chagasi
syn
leishmania
infantum
infect
dog
essenti
stop
current
spread
zoonot
viscer
leishmaniasi
therefor
vaccin
vl
would
import
tool
control
cvl
would
dramat
decreas
anxieti
regard
l
chagasi
infect
human
sens
establish
biomark
immunogen
consid
critic
ration
approach
analyz
candid
vaccin
cvl
contribut
identifi
pattern
immun
respons
dog
search
vaccin
candid
cvl
reason
work
immunogen
protect
effect
lbsapsal
vaccin
dog
investig
use
level
cytokin
evalu
relat
spleen
parasit
load
furthermor
addit
sand
fli
saliva
extract
vectorbas
vaccin
enhanc
abil
host
control
block
leishmania
infect
major
result
observ
lbsapsal
immun
reveal
reduct
level
earli
postchalleng
period
importantli
previou
studi
identifi
presenc
splenocyt
dog
natur
infect
l
chagasi
would
import
biomark
ongo
cvl
howev
report
role
relat
resist
profil
suscept
profil
cvl
higher
level
consid
hallmark
dog
natur
infect
l
chagasi
sustain
reduct
also
report
immunogen
candid
fact
reduct
level
vaccin
immun
cvl
consid
biomark
protect
leishmania
infect
present
studi
evalu
demonstr
possibl
associ
event
relat
suscept
infect
l
chagasi
control
group
present
increas
amount
late
postchalleng
period
fact
cytokin
associ
sever
vl
cvl
importantli
lbsapsal
group
increas
product
even
late
l
chagasichalleng
period
addit
analysi
reveal
reduc
product
lbsapsal
immun
group
earli
late
postchalleng
period
interestingli
presenc
associ
induc
immunosuppress
characterist
cours
vl
moreov
presenc
vitro
protect
effect
amastigot
macrophag
favor
mainten
parasit
addit
alv
et
al
report
high
level
associ
increas
parasit
load
lymph
node
symptomat
dog
conclud
associ
morbid
cvl
context
possibl
hypothes
lower
level
lbsapsal
group
would
indic
establish
immunoprotect
mechan
wherea
higher
amount
control
group
would
associ
suscept
pattern
l
chagasichalleng
analysi
proinflammatori
cytokin
consid
prerequisit
compos
immunogen
analys
experiment
challeng
l
chagasi
clinic
trial
anticvl
vaccin
analysi
vaccin
immun
demonstr
increas
level
slcastimul
cultur
control
lbsapsal
group
demonstr
tendenc
enhanc
amount
sal
lbsal
group
similar
result
observ
result
seem
indic
slca
stimul
would
induc
increas
level
cytokin
point
inher
featur
antigen
stimulu
reason
evalu
group
analyz
stimulu
group
identifi
cytokin
profil
regard
type
immun
respons
strategi
demonstr
enhanc
level
postvaccin
sustain
product
even
earli
late
postchalleng
period
lbsapsal
group
studi
describ
associ
resist
profil
cvl
dog
vaccin
cvl
associ
suscept
associ
high
level
result
obtain
straussayali
et
al
show
stimul
exogen
pbmc
l
dog
abl
revers
appar
state
anergi
result
increas
product
moreov
menezessouza
et
al
found
low
level
concomit
high
level
repres
favor
condit
persist
replic
parasit
cvl
describ
link
resist
profil
differ
experiment
model
vl
dog
vaccin
cvl
data
regard
cytokin
network
indic
balanc
immun
respons
lbsapsal
group
sens
describ
posit
versu
versu
neg
versu
correl
demonstr
promin
proinflammatori
immun
respons
lbsapsal
group
addit
nonsignific
increas
level
lbsapsal
group
balanc
immun
respons
demonstr
take
account
posit
correl
type
cytokin
data
relat
regul
promin
proinflammatori
immun
respons
induc
lbsapsal
vaccin
aim
control
potenti
tissu
damag
type
cytokin
parasitolog
evalu
reveal
lbsapsal
group
remark
reduct
spleen
parasit
load
experiment
l
chagasichalleng
concord
promin
proinflammatori
immun
respons
induc
vaccin
fact
describ
parasit
load
reduct
lbsapsal
group
indic
capac
vaccin
control
parasit
replic
even
long
challeng
day
sand
fli
saliva
display
import
role
first
step
leishmania
infect
due
vast
repertoir
pharmacolog
activ
molecul
surround
host
hemostat
system
reexposur
salivari
compon
seem
display
immunogen
activ
elicit
antibodi
product
cell
mediat
immun
host
could
block
limit
leishmania
infect
studi
shown
l
longipalpi
salivari
protein
induc
immun
respons
associ
protect
dog
furthermor
hamster
model
salivari
protein
sand
fli
protect
fatal
outcom
viscer
leishmaniasi
similarli
observ
parasit
load
reduct
sal
group
show
salivari
compon
high
potenti
limit
infect
dog
experiment
challeng
vaccin
studi
canin
viscer
leishmaniasi
consid
crucial
analyz
protect
perform
distinct
studi
publish
aim
determin
experiment
l
chagasichalleng
plu
sand
fli
saliva
use
intraderm
rout
dog
would
similar
natur
infect
intraven
challeng
howev
use
intraderm
challeng
dog
would
asymptomat
studi
besid
present
lower
parasit
sinc
lbsapsal
vaccin
present
saliva
antigen
compound
ideal
experiment
challeng
test
protect
ideal
perform
intraderm
rout
analyz
studi
importantli
observ
increas
level
lbsapsal
group
earli
late
postchalleng
period
interestingli
four
five
dog
immun
lbsapsal
present
higher
amount
low
spleen
parasit
burden
late
postchalleng
period
indic
longterm
immunogen
result
reduct
parasit
fact
previous
demonstr
lbsapsal
induc
resist
biomark
specif
relat
expans
circul
tcell
leishmaniaspecif
subset
lower
level
parasit
panaro
et
al
also
observ
increas
product
antileishmani
activ
macrophag
well
increas
level
pbmc
supernat
dog
immun
vaccin
compris
crude
antigen
l
infantum
taken
togeth
major
data
indic
immun
lbsapsal
abl
induc
protect
profil
character
enhanc
amount
type
cytokin
reduct
type
ii
cytokin
even
experiment
challeng
establish
polar
type
immun
respons
lbsapsal
immun
support
increas
level
product
favor
reduct
parasit
indic
longlast
protect
l
chagasi
infect
result
encourag
studi
provid
import
inform
better
understand
effect
lbsapsal
vaccin
strategi
address
leishmania
antigen
combin
sand
fli
protein
present
saliva
vector
